GelStat Corporation GSAC OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score

24/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

GelStat Corporation (GSAC) reported total assets of $170.89K and total liabilities of $1.22M for fiscal year 2024, resulting in total equity of $-1.05M.

The company held $8.83K in cash and short-term investments. Total debt stood at $664.56K, with net debt of $655.73K. The Debt-to-Equity (D/E) ratio was -0.63 (conservative).

Current ratio is 0.07, which may signal tight short-term liquidity. Interest coverage is -3x (weak).

Criteria supported by this page:

HEALTH (0/100, Fail) — the balance sheet shows elevated risk in debt or liquidity metrics
MOAT (50/100) — Total assets $170.89K and equity $-1.05M support the company's competitive scale

Overall SharesGrow Score: 22/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

24/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

✗

HEALTH

0/100

Debt-to-Equity & liquidity

Proven by this page

MOAT

50/100

→ Income

GROWTH

58/100

→ Income

✗

INCOME

10/100

→ Income

GelStat Corporation Balance Sheet History

Metric	FY2024	FY2023	FY2022	FY2021
Total Assets	$170.89K	$185.88K	$18.83K	$182.09K
Total Liabilities	$1.22M	$964.37K	$724.09K	$511.06K
Total Debt	$664.56K	$583.97K	$363.17K	$210.02K
Cash & Investments	$8.83K	$25.31K	$1.73K	$67.14K
Total Stockholders Equity	$-1.05M	$-778.49K	$-705.26K	$-328.97K